Article

Bausch & Lomb earns NTIOL status for two lens products

Bausch & Lomb has earned NTIOL status for its SofPort Advanced Optics and SofPort Advanced Optics with Violet Shield lenses.

Key Points

Rochester, NY-The Centers for Medicare and Medicaid Services has granted new technology IOL (NTIOL) designation to two lenses (SofPort Advanced Optics and SofPort Advanced Optics with Violet Shield, Bausch & Lomb) for their spherical aberration-reducing design.

Based on this new designation, which was effective March 6, Medicare will increase by $50 its reimbursement to ambulatory surgery centers when cataract procedures are performed with either of these lenses.

The NTIOL designation and adjusted payment will remain in effect until Feb. 26, 2011.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.